Should I Buy ANIP? ANIP 2026 Analysis

Should You Buy ANI Pharmaceuticals Inc (ANIP) Today? Analysis, Price Targets, and 2026 Outlook.

No data

Growth

Profitability

Efficiency

3 Analyst Rating

Wall Street analysts forecast ANIP stock price to rise

3 Buy

0 Hold

0 Sell

Strong Buy

Current: 83.280

Low

100

Averages

115

High

124

Current: 83.280

Low

100

Averages

115

High

124

Guggenheim

Buy

maintain

$115 -> $124

AI Analysis

2026-01-16

Reason

Guggenheim

Price Target

$115 -> $124

AI Analysis

2026-01-16

maintain

Buy

Reason

Guggenheim raised the firm's price target on ANI Pharmaceuticals to $124 from $115 and keeps a Buy rating on the shares, primarily driven by an increase to the firm's Cortrophin sales estimates following ANI's preliminary Q4 results and 2026 outlook earlier this week.

Guggenheim

Vamil Divan

Buy

maintain

$114 -> $115

2025-11-10

Reason

Guggenheim

Vamil Divan

Price Target

$114 -> $115

2025-11-10

maintain

Buy

Reason

Guggenheim analyst Vamil Divan raised the firm's price target on ANI Pharmaceuticals to $115 from $114 and keeps a Buy rating on the shares. The firm is updating its model after the company reported "yet another beat and raise quarter" and following its follow-up conversation with management.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for ANIP

Unlock Now

ANIP Should I Buy

ANIP Should I Buy

Should You Buy ANI Pharmaceuticals Inc (ANIP) Today? Analysis, Price Targets, and 2026 Outlook.

No data

No data

Growth

Profitability

Efficiency

People Also Watch